155601-65-3 Usage
General Description
2,6-Difluoronicotinaldehyde is a chemical compound with the molecular formula C6H4F2NCHO. It is an aldehyde derivative of 2,6-difluoropyridine and is used in the synthesis of various pharmaceuticals, agrochemicals, and other fine chemicals. 2,6-DIFLUORONICOTINALDEHYDE is known for its use as an intermediate in the production of pharmaceutical compounds, particularly in the field of medicinal chemistry. Its unique structure and functional groups make it a valuable building block in organic synthesis, allowing for the creation of diverse and complex chemical compounds with potential therapeutic applications. Additionally, its fluorinated structure also contributes to its potential bioactivity and pharmacokinetic properties in medicinal chemistry applications.
Check Digit Verification of cas no
The CAS Registry Mumber 155601-65-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,5,6,0 and 1 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 155601-65:
(8*1)+(7*5)+(6*5)+(5*6)+(4*0)+(3*1)+(2*6)+(1*5)=123
123 % 10 = 3
So 155601-65-3 is a valid CAS Registry Number.
InChI:InChI=1/C6H3F2NO/c7-5-2-1-4(3-10)6(8)9-5/h1-3H
155601-65-3Relevant articles and documents
CHEMOKINE RECEPTOR BINDING COMPOUNDS
-
Page/Page column 61, (2010/11/26)
The present invention relates to chemokine receptor binding compounds, pharmaceutical compositions and their use. More specifically, the present invention relates to modulators of chemokine receptor activity, preferably modulators of CCR4 or CCR5. In one aspect, these compounds demonstrate protective effects against infection of target cells by a human immunodeficiency virus (HIV).
Synthesis of some piperazinylpyrazolo[3,4-b]pyridines as selective serotonin re-uptake inhibitors
Shutske, Gregory M.,Roehr, Joachim E.
, p. 789 - 795 (2007/10/03)
A number of 3-substituted 6-piperazinylpyrazolo[3,4-b]pyridines were synthesized from 2,6-difluoropyridine by directed ortho metallation and sequential intra- and intermolecular displacement of fluorine. Three derivatives with a cyano group in the 3-position showed activity as selective serotonin re-uptake inhibitors.
